img

Global In-Vitro Toxicology and Toxicity Testing Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global In-Vitro Toxicology and Toxicity Testing Market Research Report 2024

According to MRAResearch’s new survey, global In-Vitro Toxicology and Toxicity Testing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole In-Vitro Toxicology and Toxicity Testing market research.
Key companies engaged in the In-Vitro Toxicology and Toxicity Testing industry include GE Healthcare, Thermo Fisher Scientific, Bio-Rad Laboratories, Agilent Technologies, Cyprotex, Covance, Bioreliance, Catalent and Charles River Laboratories International, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of In-Vitro Toxicology and Toxicity Testing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole In-Vitro Toxicology and Toxicity Testing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global In-Vitro Toxicology and Toxicity Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


GE Healthcare
Thermo Fisher Scientific
Bio-Rad Laboratories
Agilent Technologies
Cyprotex
Covance
Bioreliance
Catalent
Charles River Laboratories International
Alere
Eurofins Scientific
Life Technologies Corporation
Quest Diagnostics
Segment by Type
Cell Culture Technology
High Throughput Technologies
Molecular Imaging Technologies
Omics Technologies

Segment by Application


Pharmaceutical Industry
Chemical Industry
Food Industry
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The In-Vitro Toxicology and Toxicity Testing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-Vitro Toxicology and Toxicity Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Cell Culture Technology
1.2.3 High Throughput Technologies
1.2.4 Molecular Imaging Technologies
1.2.5 Omics Technologies
1.3 Market by Application
1.3.1 Global In-Vitro Toxicology and Toxicity Testing Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Pharmaceutical Industry
1.3.3 Chemical Industry
1.3.4 Food Industry
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In-Vitro Toxicology and Toxicity Testing Market Perspective (2018-2033)
2.2 In-Vitro Toxicology and Toxicity Testing Growth Trends by Region
2.2.1 Global In-Vitro Toxicology and Toxicity Testing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 In-Vitro Toxicology and Toxicity Testing Historic Market Size by Region (2018-2023)
2.2.3 In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Region (2024-2033)
2.3 In-Vitro Toxicology and Toxicity Testing Market Dynamics
2.3.1 In-Vitro Toxicology and Toxicity Testing Industry Trends
2.3.2 In-Vitro Toxicology and Toxicity Testing Market Drivers
2.3.3 In-Vitro Toxicology and Toxicity Testing Market Challenges
2.3.4 In-Vitro Toxicology and Toxicity Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-Vitro Toxicology and Toxicity Testing Players by Revenue
3.1.1 Global Top In-Vitro Toxicology and Toxicity Testing Players by Revenue (2018-2023)
3.1.2 Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Players (2018-2023)
3.2 Global In-Vitro Toxicology and Toxicity Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In-Vitro Toxicology and Toxicity Testing Revenue
3.4 Global In-Vitro Toxicology and Toxicity Testing Market Concentration Ratio
3.4.1 Global In-Vitro Toxicology and Toxicity Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-Vitro Toxicology and Toxicity Testing Revenue in 2022
3.5 In-Vitro Toxicology and Toxicity Testing Key Players Head office and Area Served
3.6 Key Players In-Vitro Toxicology and Toxicity Testing Product Solution and Service
3.7 Date of Enter into In-Vitro Toxicology and Toxicity Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In-Vitro Toxicology and Toxicity Testing Breakdown Data by Type
4.1 Global In-Vitro Toxicology and Toxicity Testing Historic Market Size by Type (2018-2023)
4.2 Global In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Type (2024-2033)
5 In-Vitro Toxicology and Toxicity Testing Breakdown Data by Application
5.1 Global In-Vitro Toxicology and Toxicity Testing Historic Market Size by Application (2018-2023)
5.2 Global In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America In-Vitro Toxicology and Toxicity Testing Market Size (2018-2033)
6.2 North America In-Vitro Toxicology and Toxicity Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2018-2023)
6.4 North America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In-Vitro Toxicology and Toxicity Testing Market Size (2018-2033)
7.2 Europe In-Vitro Toxicology and Toxicity Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Country (2018-2023)
7.4 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size (2018-2033)
8.2 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In-Vitro Toxicology and Toxicity Testing Market Size (2018-2033)
9.2 Latin America In-Vitro Toxicology and Toxicity Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2018-2023)
9.4 Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size (2018-2033)
10.2 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Detail
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare In-Vitro Toxicology and Toxicity Testing Introduction
11.1.4 GE Healthcare Revenue in In-Vitro Toxicology and Toxicity Testing Business (2018-2023)
11.1.5 GE Healthcare Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific In-Vitro Toxicology and Toxicity Testing Introduction
11.2.4 Thermo Fisher Scientific Revenue in In-Vitro Toxicology and Toxicity Testing Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Detail
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories In-Vitro Toxicology and Toxicity Testing Introduction
11.3.4 Bio-Rad Laboratories Revenue in In-Vitro Toxicology and Toxicity Testing Business (2018-2023)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Detail
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies In-Vitro Toxicology and Toxicity Testing Introduction
11.4.4 Agilent Technologies Revenue in In-Vitro Toxicology and Toxicity Testing Business (2018-2023)
11.4.5 Agilent Technologies Recent Development
11.5 Cyprotex
11.5.1 Cyprotex Company Detail
11.5.2 Cyprotex Business Overview
11.5.3 Cyprotex In-Vitro Toxicology and Toxicity Testing Introduction
11.5.4 Cyprotex Revenue in In-Vitro Toxicology and Toxicity Testing Business (2018-2023)
11.5.5 Cyprotex Recent Development
11.6 Covance
11.6.1 Covance Company Detail
11.6.2 Covance Business Overview
11.6.3 Covance In-Vitro Toxicology and Toxicity Testing Introduction
11.6.4 Covance Revenue in In-Vitro Toxicology and Toxicity Testing Business (2018-2023)
11.6.5 Covance Recent Development
11.7 Bioreliance
11.7.1 Bioreliance Company Detail
11.7.2 Bioreliance Business Overview
11.7.3 Bioreliance In-Vitro Toxicology and Toxicity Testing Introduction
11.7.4 Bioreliance Revenue in In-Vitro Toxicology and Toxicity Testing Business (2018-2023)
11.7.5 Bioreliance Recent Development
11.8 Catalent
11.8.1 Catalent Company Detail
11.8.2 Catalent Business Overview
11.8.3 Catalent In-Vitro Toxicology and Toxicity Testing Introduction
11.8.4 Catalent Revenue in In-Vitro Toxicology and Toxicity Testing Business (2018-2023)
11.8.5 Catalent Recent Development
11.9 Charles River Laboratories International
11.9.1 Charles River Laboratories International Company Detail
11.9.2 Charles River Laboratories International Business Overview
11.9.3 Charles River Laboratories International In-Vitro Toxicology and Toxicity Testing Introduction
11.9.4 Charles River Laboratories International Revenue in In-Vitro Toxicology and Toxicity Testing Business (2018-2023)
11.9.5 Charles River Laboratories International Recent Development
11.10 Alere
11.10.1 Alere Company Detail
11.10.2 Alere Business Overview
11.10.3 Alere In-Vitro Toxicology and Toxicity Testing Introduction
11.10.4 Alere Revenue in In-Vitro Toxicology and Toxicity Testing Business (2018-2023)
11.10.5 Alere Recent Development
11.11 Eurofins Scientific
11.11.1 Eurofins Scientific Company Detail
11.11.2 Eurofins Scientific Business Overview
11.11.3 Eurofins Scientific In-Vitro Toxicology and Toxicity Testing Introduction
11.11.4 Eurofins Scientific Revenue in In-Vitro Toxicology and Toxicity Testing Business (2018-2023)
11.11.5 Eurofins Scientific Recent Development
11.12 Life Technologies Corporation
11.12.1 Life Technologies Corporation Company Detail
11.12.2 Life Technologies Corporation Business Overview
11.12.3 Life Technologies Corporation In-Vitro Toxicology and Toxicity Testing Introduction
11.12.4 Life Technologies Corporation Revenue in In-Vitro Toxicology and Toxicity Testing Business (2018-2023)
11.12.5 Life Technologies Corporation Recent Development
11.13 Quest Diagnostics
11.13.1 Quest Diagnostics Company Detail
11.13.2 Quest Diagnostics Business Overview
11.13.3 Quest Diagnostics In-Vitro Toxicology and Toxicity Testing Introduction
11.13.4 Quest Diagnostics Revenue in In-Vitro Toxicology and Toxicity Testing Business (2018-2023)
11.13.5 Quest Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global In-Vitro Toxicology and Toxicity Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Cell Culture Technology
Table 3. Key Players of High Throughput Technologies
Table 4. Key Players of Molecular Imaging Technologies
Table 5. Key Players of Omics Technologies
Table 6. Global In-Vitro Toxicology and Toxicity Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global In-Vitro Toxicology and Toxicity Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global In-Vitro Toxicology and Toxicity Testing Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global In-Vitro Toxicology and Toxicity Testing Market Share by Region (2018-2023)
Table 10. Global In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global In-Vitro Toxicology and Toxicity Testing Market Share by Region (2024-2033)
Table 12. In-Vitro Toxicology and Toxicity Testing Market Trends
Table 13. In-Vitro Toxicology and Toxicity Testing Market Drivers
Table 14. In-Vitro Toxicology and Toxicity Testing Market Challenges
Table 15. In-Vitro Toxicology and Toxicity Testing Market Restraints
Table 16. Global In-Vitro Toxicology and Toxicity Testing Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global In-Vitro Toxicology and Toxicity Testing Market Share by Players (2018-2023)
Table 18. Global Top In-Vitro Toxicology and Toxicity Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Toxicology and Toxicity Testing as of 2022)
Table 19. Ranking of Global Top In-Vitro Toxicology and Toxicity Testing Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by In-Vitro Toxicology and Toxicity Testing Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players In-Vitro Toxicology and Toxicity Testing Product Solution and Service
Table 23. Date of Enter into In-Vitro Toxicology and Toxicity Testing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global In-Vitro Toxicology and Toxicity Testing Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Type (2018-2023)
Table 27. Global In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Type (2024-2033)
Table 29. Global In-Vitro Toxicology and Toxicity Testing Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Application (2018-2023)
Table 31. Global In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Application (2024-2033)
Table 33. North America In-Vitro Toxicology and Toxicity Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe In-Vitro Toxicology and Toxicity Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe In-Vitro Toxicology and Toxicity Testing Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe In-Vitro Toxicology and Toxicity Testing Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America In-Vitro Toxicology and Toxicity Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Country (2024-2033) & (US$ Million)
Table 48. GE Healthcare Company Detail
Table 49. GE Healthcare Business Overview
Table 50. GE Healthcare In-Vitro Toxicology and Toxicity Testing Product
Table 51. GE Healthcare Revenue in In-Vitro Toxicology and Toxicity Testing Business (2018-2023) & (US$ Million)
Table 52. GE Healthcare Recent Development
Table 53. Thermo Fisher Scientific Company Detail
Table 54. Thermo Fisher Scientific Business Overview
Table 55. Thermo Fisher Scientific In-Vitro Toxicology and Toxicity Testing Product
Table 56. Thermo Fisher Scientific Revenue in In-Vitro Toxicology and Toxicity Testing Business (2018-2023) & (US$ Million)
Table 57. Thermo Fisher Scientific Recent Development
Table 58. Bio-Rad Laboratories Company Detail
Table 59. Bio-Rad Laboratories Business Overview
Table 60. Bio-Rad Laboratories In-Vitro Toxicology and Toxicity Testing Product
Table 61. Bio-Rad Laboratories Revenue in In-Vitro Toxicology and Toxicity Testing Business (2018-2023) & (US$ Million)
Table 62. Bio-Rad Laboratories Recent Development
Table 63. Agilent Technologies Company Detail
Table 64. Agilent Technologies Business Overview
Table 65. Agilent Technologies In-Vitro Toxicology and Toxicity Testing Product
Table 66. Agilent Technologies Revenue in In-Vitro Toxicology and Toxicity Testing Business (2018-2023) & (US$ Million)
Table 67. Agilent Technologies Recent Development
Table 68. Cyprotex Company Detail
Table 69. Cyprotex Business Overview
Table 70. Cyprotex In-Vitro Toxicology and Toxicity Testing Product
Table 71. Cyprotex Revenue in In-Vitro Toxicology and Toxicity Testing Business (2018-2023) & (US$ Million)
Table 72. Cyprotex Recent Development
Table 73. Covance Company Detail
Table 74. Covance Business Overview
Table 75. Covance In-Vitro Toxicology and Toxicity Testing Product
Table 76. Covance Revenue in In-Vitro Toxicology and Toxicity Testing Business (2018-2023) & (US$ Million)
Table 77. Covance Recent Development
Table 78. Bioreliance Company Detail
Table 79. Bioreliance Business Overview
Table 80. Bioreliance In-Vitro Toxicology and Toxicity Testing Product
Table 81. Bioreliance Revenue in In-Vitro Toxicology and Toxicity Testing Business (2018-2023) & (US$ Million)
Table 82. Bioreliance Recent Development
Table 83. Catalent Company Detail
Table 84. Catalent Business Overview
Table 85. Catalent In-Vitro Toxicology and Toxicity Testing Product
Table 86. Catalent Revenue in In-Vitro Toxicology and Toxicity Testing Business (2018-2023) & (US$ Million)
Table 87. Catalent Recent Development
Table 88. Charles River Laboratories International Company Detail
Table 89. Charles River Laboratories International Business Overview
Table 90. Charles River Laboratories International In-Vitro Toxicology and Toxicity Testing Product
Table 91. Charles River Laboratories International Revenue in In-Vitro Toxicology and Toxicity Testing Business (2018-2023) & (US$ Million)
Table 92. Charles River Laboratories International Recent Development
Table 93. Alere Company Detail
Table 94. Alere Business Overview
Table 95. Alere In-Vitro Toxicology and Toxicity Testing Product
Table 96. Alere Revenue in In-Vitro Toxicology and Toxicity Testing Business (2018-2023) & (US$ Million)
Table 97. Alere Recent Development
Table 98. Eurofins Scientific Company Detail
Table 99. Eurofins Scientific Business Overview
Table 100. Eurofins Scientific In-Vitro Toxicology and Toxicity Testing Product
Table 101. Eurofins Scientific Revenue in In-Vitro Toxicology and Toxicity Testing Business (2018-2023) & (US$ Million)
Table 102. Eurofins Scientific Recent Development
Table 103. Life Technologies Corporation Company Detail
Table 104. Life Technologies Corporation Business Overview
Table 105. Life Technologies Corporation In-Vitro Toxicology and Toxicity Testing Product
Table 106. Life Technologies Corporation Revenue in In-Vitro Toxicology and Toxicity Testing Business (2018-2023) & (US$ Million)
Table 107. Life Technologies Corporation Recent Development
Table 108. Quest Diagnostics Company Detail
Table 109. Quest Diagnostics Business Overview
Table 110. Quest Diagnostics In-Vitro Toxicology and Toxicity Testing Product
Table 111. Quest Diagnostics Revenue in In-Vitro Toxicology and Toxicity Testing Business (2018-2023) & (US$ Million)
Table 112. Quest Diagnostics Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In-Vitro Toxicology and Toxicity Testing Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global In-Vitro Toxicology and Toxicity Testing Market Share by Type: 2022 VS 2033
Figure 3. Cell Culture Technology Features
Figure 4. High Throughput Technologies Features
Figure 5. Molecular Imaging Technologies Features
Figure 6. Omics Technologies Features
Figure 7. Global In-Vitro Toxicology and Toxicity Testing Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global In-Vitro Toxicology and Toxicity Testing Market Share by Application: 2022 VS 2033
Figure 9. Pharmaceutical Industry Case Studies
Figure 10. Chemical Industry Case Studies
Figure 11. Food Industry Case Studies
Figure 12. Other Case Studies
Figure 13. In-Vitro Toxicology and Toxicity Testing Report Years Considered
Figure 14. Global In-Vitro Toxicology and Toxicity Testing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global In-Vitro Toxicology and Toxicity Testing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global In-Vitro Toxicology and Toxicity Testing Market Share by Region: 2022 VS 2033
Figure 17. Global In-Vitro Toxicology and Toxicity Testing Market Share by Players in 2022
Figure 18. Global Top In-Vitro Toxicology and Toxicity Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Toxicology and Toxicity Testing as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by In-Vitro Toxicology and Toxicity Testing Revenue in 2022
Figure 20. North America In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America In-Vitro Toxicology and Toxicity Testing Market Share by Country (2018-2033)
Figure 22. United States In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe In-Vitro Toxicology and Toxicity Testing Market Share by Country (2018-2033)
Figure 26. Germany In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Share by Region (2018-2033)
Figure 34. China In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America In-Vitro Toxicology and Toxicity Testing Market Share by Country (2018-2033)
Figure 42. Mexico In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Share by Country (2018-2033)
Figure 46. Turkey In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. GE Healthcare Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2018-2023)
Figure 49. Thermo Fisher Scientific Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2018-2023)
Figure 50. Bio-Rad Laboratories Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2018-2023)
Figure 51. Agilent Technologies Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2018-2023)
Figure 52. Cyprotex Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2018-2023)
Figure 53. Covance Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2018-2023)
Figure 54. Bioreliance Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2018-2023)
Figure 55. Catalent Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2018-2023)
Figure 56. Charles River Laboratories International Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2018-2023)
Figure 57. Alere Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2018-2023)
Figure 58. Eurofins Scientific Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2018-2023)
Figure 59. Life Technologies Corporation Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2018-2023)
Figure 60. Quest Diagnostics Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed